ADXS Short Information, Advaxis Inc.

Twenty Trading Day Totals
Total Shorted Volume	10,921,408
Total Actual Volume	89,483,630

Averages
Average Short Volume	546,070
Average Short Percentage	50.72%

Is there a ADXS Short Squeeze or Breakout about to happen?

See the ADXS Short Analysis for free Sign up or Login

Stock Date	Open Price	Close Price	High	Low	Total Volume	Short Volume	Short Percentage
2020-04-02	0.54	0.5242	0.54	0.515	915,566	286,185	69.5388
2020-04-01	0.53	0.5324	0.55	0.52	977,558	243,017	69.8230
2020-03-31	0.536	0.53	0.5599	0.52	783,487	131,489	47.7172
2020-03-30	0.555	0.5422	0.56	0.53	861,579	141,662	46.8842
2020-03-27	0.5879	0.559	0.5879	0.5403	827,385	120,387	47.4407
2020-03-26	0.6	0.59	0.64	0.572	1,510,004	175,389	39.0779
2020-03-25	0.5564	0.596	0.65	0.528	2,057,080	344,372	40.1146
2020-03-24	0.54	0.5498	0.57	0.5022	1,801,188	290,659	44.1593
2020-03-23	0.52	0.51	0.54	0.4801	1,410,313	226,536	44.4353
2020-03-20	0.57	0.55	0.59	0.53	1,361,471	212,859	41.0927
2020-03-19	0.53	0.555	0.58	0.51	1,101,049	126,886	34.9201
2019-12-05	0.6083	0.63	0.648	0.581	4,080,052	580,196	59.0504
2019-12-04	0.5879	0.602	0.6339	0.55	6,213,791	729,538	52.4770
2019-12-03	0.61	0.5766	0.688	0.5218	14,258,516	1,380,596	48.2743
2019-12-02	0.51	0.63	0.65	0.50	20,486,474	2,053,496	50.6873
2019-11-29	0.436	0.5142	0.515	0.435	7,428,800	1,017,510	60.3187
2019-11-27	0.4077	0.435	0.443	0.397	3,613,015	435,277	52.2918
2019-11-26	0.4272	0.41	0.43	0.3999	4,161,470	465,975	55.1544
2019-11-25	0.4432	0.432	0.467	0.4101	5,375,846	600,043	46.3918
2019-11-22	0.40	0.4422	0.4665	0.3902	10,258,986	1,359,336	64.5912

Stock Information

Advaxis Inc. Company Name:

ADXS Stock Symbol:

NASDAQ Market:

Advaxis Inc. Website:

ADXS Short Information, Advaxis Inc.

Get ADXS Alerts

News, Short Squeeze, Breakout and More Instantly...

RECENT ADXS NEWS

ADXS - Advaxis Is One Biotech That Should Be On Your Radar; Targeting Large NSCLC And Prostate Cancer Drug Markets

Advaxis ( ADXS ) announced positive results from its Phase 1/2 study using ADXS-503 to treat patients with non-small cell lung cancer (NSCLC). These results were presented at a medical conference. They were preliminary results, but nonetheless were still impressive as these patients were h...
ADXS - Advaxis EPS beats by $0.04

Advaxis (NASDAQ: ADXS ): Q1 GAAP EPS of -$0.15 beats by $0.04 . More news on: Advaxis, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
ADXS - Advaxis Reports First Quarter Ended January 31, 2020 Financial Results and Provides a Pipeline Update

PRINCETON, N.J., March 13, 2020 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products today announced an update on its clinical pipeline and financial results for the first quarter ...